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Introduction
　Sarles et al described autoimmune pancreatitis （AIP） for 
the first time in ₁₉₆₁₁ ︶, and AIP was established as a clinical 
entity by Yoshida et al in ₁₉₉₅ ₂ ︶. Typical AIP is a reversible 
inflammatory disease of the pancreas associated with other 
o rgans  invo lvement s  such  as  the  b i l i a ry  sys tem, 
retroperitoneal organs, lacrimal/salivary glands and 
mediastinal/abdominal lymphoadenopathy ₃ ︶. However, AIP is 
sometimes misdiagnosed as pancreatic cancer and treated 
mistakenly by surgical  resection.  AIP is  becoming 
increasingly well recognized due to the evolving awareness 
about the disease and possibility of making the correct 
diagnosis based on consensus diagnostic criteria criteria ₄ ）. 
Diagnosis of typical AIP is no longer difficult, because of the 
existence of reliable international consensus guidelines ₅ ）. AIP 
is visualized as a diffuse swelling of the pancreas with a 
capsular rim on computed tomography （CT︶, although it 
sometimes manifests as a focal mass lesion mimicking 
pancreatic cancer ₆ ︶. In addition, focal type AIP patients often 
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Abstract：Autoimmune pancreatitis （AIP） has come to be increasingly recognized due to the evolving 
awareness about the disease and the possibility of making a correct diagnosis based on consensus diagnostic 
criteria. Diagnosis of AIP is no longer difficult, because of the existence of reliable international consensus 
guidelines. AIP is visualized as a diffuse swelling of the pancreas with a capsular rim on computed tomography, 
although it sometimes manifests as a focal mass lesion mimicking pancreatic cancer. Endoscopic 
ultrasonography （EUS） could play pivotal role in the diagnosis of AIP in that it can provide real-time imaging 
findings of early chronic pancreatitis, including features such as foci/stranding, lobularity and a hyperechoic 
pancreatic duct margin, and also features of advanced pancreatitis such as cyst formation, dilatation of the side 
branches of the pancreatic duct and calcification. EUS-guided fine-needle aspiration biopsy （EUS-FNA） also 
allows tissue specimens to be obtained, which could be processed for histopathology and immunohistochemistry 
for the diagnosis of type ₂  AIP. EUS-elastography and contrast-enhanced EUS are also promising techniques. 
要　旨：自己免疫性膵炎は，最近その存在が注目されている疾患であり，正確な診断は確立された国
際診断基準による．超音波内視鏡（EUS）はその中で，診断に重要な役割を担っている－早期慢性膵
炎の診断基準項目である foci，stranding，loburality，hyperechoic pancreatic duct margins，そして非代償
期を示すcyst， dilatation of the side branch duct and calcificationにより，AIPの診断に寄与する．さらに
EUS－FNAによる組織診断も免疫染色を付加することで可能であり， ₂ 型AIPを診断できる可能性
もある．EUS－elastographyや造影EUSの有用性も期待できるが発展段階である．
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show negative test results for serum IgG₄, which may also 
make the diagnosis difficult ₇ ︶. Some patients with focal type 
₁  and/or type ₂  AIP may undergo unnecessary surgery 
because of the difficulty in differentiating this condition from 
cancer based on the symptoms and imaging findings without 
histopathological evidence. Under this circumstance, 
Endoscopic ultrasonography （EUS） could be a useful tool to 
diagnose AIP in that it can provide real-time images useful for 
the diagnosis and also allow specimens to be obtained for 
histopathological and immunohistochemical analysis ₈ ︶. This 
review is aimed at highlighting the roles of EUS in the 
diagnosis of AIP.
Endosonographic features
　Endosonograhic findings of chronic pancreatitis can be 
divided into parenchymal （foci/stranding, lobularity, cyst） and 
ductal （hyperechoic main pancreatic duct margin, dilated side 
b r a n c h e s） f e a t u r e s ₉ ︶.  C o r r e l a t i o n s  b e t w e e n  t h e 
endosonographic findings and histopathologic features in 
patients with AIP are shown in Table ₁ . These findings can aid 
in the diagnosis of AIP₁₀︶. Hyperechoic foci are defined as 
hyperechoic structures measuring more than ₂  mm in length 
and width that produced shadow. Histopathologically, these 
foci correspond to focal fibrosis. Stranding is defined as the 
presence of at least three hyperechoic lines measuring more 
than ₃  mm in length and corresponds histopathologically to 
bridging fibrosis. Lobularity on endosonography is defined as 
the presence of well-circumscribed structures measuring more 
than ₅  mm in diameter, with rims that are hyperechoic 
relative to the echogenicity of the central area. At least three 
lobules in the body/tail of the pancreas must be present to 
define lobularity. Honeycomb lobularity refers to the presence 
of at least three lobules that are contiguous with each other. 
Cysts indicate abnormal anechoic round or oval structures, 
corresponding histopathologically to retention cysts or 
pseudocysts. A hyperechoic main pancreatic duct margin is 
defined as a relatively hyperechoic duct wall in greater than 
₅₀% of the entire length of the main pancreatic duct in the 
body and tail, and corresponds to periductal fibrosis. Dilated 
side branches are defined as the presence of three or more 
tubular anechoic structures measuring more than ₁  mm in 
width each and communicating with the main pancreatic duct. 
Endosonographic images can increase the diagnostic accuracy 
of AIP in patients with negative workup for atypical AIP₁₀︶. 
The prevailing diagnostic criteria for AIP include CT, 
magnetic resonance imaging （MRI） and endoscopic 
retrograde cholangiopancreatography （ERCP） findings, but 
not endosonographic findings. While EUS provides high-
definition imaging of the pancreas, EUS features alone are not 
sufficient for the diagnosis of AIP because EUS couldn＇t 
reveal the focal narrowing irregular pancreatic duct stricture 
for focal type AIP, which can be shown on ERCP or magnetic 
resonance cholangiopancreatography （MRCP）₅  ,₁₀）. In addition 
to providing endosonographic images, EUS is also useful for 
obtaining t issue specimens for  histopathology and 
immunohistochemistry. The endosonographic features of AIP 
include diffusely enlarged sausage-liked hypoechoic swelling 
of the pancreas. Cysts and/or calcification are not recognized 
in the reversible phase which is responsive to corticosteroid 
treatment （CST︶︵Figure ₁︶. AIP can be classified into early-
s tage  d isease  （character ized by good response  to 
corticosteroid therapy︶,  and advanced-stage disease 
（characterized by stone and cyst formation, similar to the 
findings in chronic alcoholic pancreatitis︶₁₀︶. Advanced 
chronic pancreatitis is associated with irregular dilatation of 
the main pancreatic duct and calculi and/or cyst formation. We 
suggested that lobularity and a hyperechoic pancreatic duct 
margin were characteristic EUS features of early AIP, which 
had a more favorable prognosis, with a higher frequency of 
spontaneous remission and preservation of acinar cells than 
advanced AIP₁₀）. Focal type AIP may be difficult to 
differentiate from pancreatic cancer in the absence of 
histopathological evidence. 
Figure ₁ . Endosonographic features in patients of autoimmune pancreatitis.
Table ₁ . Correlation between endosography and histopathology in autoimmune
 pancreatitis.
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AIP and early chronic pancreatitis
　Early chronic pancreatitis is a reversible entity just like 
AIP₁₁）. Sahai described the endosonographic diagnostic criteria 
for the diagnosis of chronic pancreatitis using terms such as 
hyperechoic foci, stranding, lobilarity, hyperechoic duct 
margin, dilated side branches, cysts and pancreatic lithiasis₁₂） 
（Table ₁︶ .  We showed that some of Sahai ＇s criteria 
corresponded to the diagnostic criteria of AIP, because the 
endosonographic images of AIP are almost the same as those 
of early chronic pancreatitis. Sausage-like swollen pancreas 
with reduced echogenicity （Figure ₂︶, foci （Figure ₃︶, 
stranding （Figure ₄︶, lobulation （Figure ₅） and a hyperechoic 
duct margin （Figure ₆） are frequently recognized in patients 
with early-stage AIP, which is often responsive to CST. CST 
can lead to rapid resolution of the clinical, imaging as well as 
histopathological abnormalities in patients with AIP. Figure ₂  
indicates the transition of the endosonographic findings of 
AIP: a hyperechoic duct margin, foci/stranding and lobularity 
are noted in the early phase, while all of these features become 
less pronounced in the advanced phase. On the other hand, 
dilated side branches, cyst formation （Figure ₇） and 
Figure ₂ . Sausage like swollen pancreas(arrow head) with reduced 
echo in patien with autoimmue pancreatitis.
Figure ₄ . Stranding(arrow head) was recognized in patient with 
autoimmune pancreatitis.
Figure ₃ . Non shadowing hyperechoic foci(arrow head) in 
patient with autoimmune pancreatitis..
Figure ₅ . Pancreatic parenchyma demonstrating honeycomb 
lobularity(arrow) in patient with autoimmune pancreatitis.
Figure ₆ . The pancreatic duct is tortuous with hyperechoic duct 
margins(arrow head) in patient with autoimmune pancreatitis.
Figure ₇ . Retention cysts recognized in patient with autoimmune 
pancreatitis, foci also noted.
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pancreatolithiasis are the landmarks of the late phase of AIP.
EUS elastography （EUS-ela）
　The usefulness of EUS-elastography （EUS-ela） in 
differentiating AIP from pancreatic cancer has been under 
debate. EUS-ela is a non-invasive technique for measuring the 
elasticity of a tissue in real time. Quantitative elastography 
provides the ratio of the elasticity of a target tissue over that of 
a soft reference tissue （strain ratio︶₁₃︶. Different pathological 
features such as inflammation, fibrosis and cancer can change 
the tissue elasticity and confer distinct elastographic 
appearances₁₄︶. Giovannini studied EUS-ela based on 
qualitative elastographic evaluation. The sensitivity and 
specificity for differentiating between benign and malignant 
pancreatic masses were ₁₀₀% and ₆₇%, respectively. EUS-ela 
is a state-of-the art technique to diagnose pancreatic cancer. It 
can provide characteristic elastographic features of both focal 
tumors and the surrounding areas₁₅︶. Iglesias et al₁₃） evaluated 
the strain ratios of solid pancreatic masses in ₈₆ patients, 
including ₂₇ inflammatory masses. The strain ratios of 
malignant tumors were significantly higher as compared to 
those of inflammatory masses. The mean strain ratio of the 
normal pancreas was ₁.₆₈ （₉₅% CI: ₁.₅₈-₁.₇₈︶, that of 
inflammatory masses was ₃.₂₈ （₉₅% CI: ₂.₆₁-₃.₉₈︶, and that 
of pancreatic cancer was ₁₈.₁₂ （₉₅% CI: ₁₆.₀₃-₂₀.₂₁︶. EUS-
ela was useful for detecting the hard lesions in patients with 
AIP （Figure ₈︶, （Figure ₉）. However, quantitative evaluation 
is subject-dependent, and further evidence needs to be 
accumulated.
Contrast-enhanced EUS （CE-EUS）
　CE-EUS, which provides perfusion images is used to 
validate the vascularity of pancreatic mass lesions, including 
focal type AIP and pancreatic cancer₁₆︶. This technique is 
considered useful as it provides images of contrast flow in the 
blood vessels without the burden of Doppler-related artifacts. 
Napoleon et al showed that the finding of a hypo-enhancing 
lesion on CE-EUS is associated with a sensitivity, specificity 
and accuracy for the diagnosis of malignancy of ₈₉%, ₈₈% 
and ₈₈.₅%, respectively₁₇︶. Imazu et al₁₈） attempted to 
Figure ₈ . Elastography showed hard lesion (blue) in patient with 
autoimmune pancreatitis.
Figure₁₀. EUS-FNA using ₂₂ gauge needle.
Figure ₉ . Elastography strain ratio indicated ₂ .₆₇ in patient with 
autoimmune pancreatitis, which tended to be lower than that with in 
patient with pancreatic cancer(mean ₁₈.₁₂₁₃）).
Figure₁₁. FNA specimen(arrow) obtained by ₂₂ gauge needle; 
autoimmune pancreatitis (reversible stage).
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differentiate AIP from pancreatic cancer on CE-EUS by 
carrying out quantitative analysis of the perfusion using a 
time-intensity curve. Recent data indicate that AIP can show 
hypervascular i ty,  whi le  pancrea t ic  cancer  can  be 
hypovascular₁₉︶.
EUS-guided fine-needle aspiration biopsy （EUS-FNA）
　The most important role of EUS-FNA is that it aids in the 
differentiation of focal-type AIP （Figure ₁₀, ₁₁） from 
pancreatic cancer, although EUS-FNA findings alone are not 
sufficient to exclude pancreatic cancer. As negative results of 
EUS-FNA do not confirm the benign nature of a disease, 
repeated EUS-FNA biopsies or short-term follow-up imaging 
is mandatory₂₀）. To diagnose AIP correctly, obtaining sufficient 
material for immunohistopathology is essential₂₁︶. As AIP is 
characterized by patchy and/or focal involvement of the 
pancreas, sampling errors can occur, therefore, repeated EUS-
FNA biopsies may be necessary to exclude malignancy₂₂）. 
True-cut needle might be the most reliable for the diagnosis of 
AIP₂₃︶, however, true-cut biopsy is technically challenging, 
and in addition, is associated with a high risk of complications 
and is particularly difficult for lesions in the head of the 
pancreas. Thinner ₂₂/₂₅ gauge needles are not always suitable 
to get sufficient tissue, while a ₁₉-gauge needle is suitable for 
non-surgical diagnosis₂₄︶. AIP is divided into two types, type 
₁  and type ₂ . Typical type ₁  AIP, an IgG ₄ -related disease, 
can be diagnosed according to the International Consensus 
Diagnostic Criteria （ICDC） criteria ₅ ︶, additionally, EUS-FNA 
could play an important role in the diagnosis of focal-type 
₁ A I P.  O n  t h e  o t h e r  h a n d s ,  t y p e  ₂  A I P n e e d e d 
histopathological evidences alone but cytology₂₅︶. Recently, 
Kanno et al₂₆） showed that EUS-FNA with a ₂₂-gauge needle 
using the quick motion method plus careful handling and 
processing of histological specimens is effective for the 
diagnosis. 
Conclusion
　EUS could play pivotal roles in the diagnosis of AIP in that 
it can provide real-time imaging findings of early chronic 
pancreatitis, including features such as foci/stranding, 
lobularity and a hyperechoic pancreatic duct margin, and also 
features of advanced pancreatitis such as cyst formation, 
dilatation of the side branches of the pancreatic duct and 
calcification. EUS-FNA also allows tissue specimens to be 
obtained, which could be processed for histopathology and 
immunohistochemistry for the diagnosis of type ₂  AIP. EUS-
elastography and contrast-enhanced EUS could be 
supplemental techniques in the different diagnosis for AIP. 
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